[HTML][HTML] Current status of probiotic and related health benefits
This review is aimed to explore the health beneficial effects of probiotics which are live
microorganisms that provide a positive health influence on humans when taken in sufficient …
microorganisms that provide a positive health influence on humans when taken in sufficient …
[HTML][HTML] Role of gut microbiota via the gut-liver-brain axis in digestive diseases
JH Ding, Z Jin, XX Yang, J Lou, WX Shan… - World Journal of …, 2020 - ncbi.nlm.nih.gov
The gut-brain axis is a bidirectional information interaction system between the central
nervous system (CNS) and the gastrointestinal tract, in which gut microbiota plays a key role …
nervous system (CNS) and the gastrointestinal tract, in which gut microbiota plays a key role …
The Effect of Probiotics (MCP® BCMC® Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non …
MH Mohamad Nor, N Ayob, NM Mokhtar, RA Raja Ali… - Nutrients, 2021 - mdpi.com
Treatment for non-alcoholic fatty liver disease (NAFLD) currently consists of lifestyle
modifications such as a low-fat diet, weight loss, and exercise. The gut microbiota forms part …
modifications such as a low-fat diet, weight loss, and exercise. The gut microbiota forms part …
The role of gut–liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC
Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most prevalent chronic
liver diseases worldwide due to the rapidly rising prevalence of obesity and metabolic …
liver diseases worldwide due to the rapidly rising prevalence of obesity and metabolic …
[HTML][HTML] Understanding the effects of gut microbiota dysbiosis on nonalcoholic fatty liver disease and the possible probiotics role: recent updates
Nonalcoholic fatty liver disease (NAFLD) is leading chronic liver syndrome worldwide. Gut
microbiota dysbiosis significantly contributes to the pathogenesis and severity of NAFLD …
microbiota dysbiosis significantly contributes to the pathogenesis and severity of NAFLD …
[HTML][HTML] Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …
The role of the gut microbiome in liver cirrhosis treatment
NY Lee, KT Suk - International journal of molecular sciences, 2020 - mdpi.com
Liver cirrhosis is one of the most prevalent chronic liver diseases worldwide. In addition to
viral hepatitis, diseases such as steatohepatitis, autoimmune hepatitis, sclerosing …
viral hepatitis, diseases such as steatohepatitis, autoimmune hepatitis, sclerosing …
Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
Patients with chronic liver disease and cirrhosis demonstrate a global mucosal immune
impairment, which is associated with altered gut microbiota composition and functionality …
impairment, which is associated with altered gut microbiota composition and functionality …
Chronic liver diseases and the microbiome—translating our knowledge of gut microbiota to management of chronic liver disease
Chronic liver disease is reaching epidemic proportions with the increasing prevalence of
obesity, nonalcoholic liver disease, and alcohol overuse worldwide. Most patients are not …
obesity, nonalcoholic liver disease, and alcohol overuse worldwide. Most patients are not …
Current research on the pathogenesis of NAFLD/NASH and the gut–liver axis: gut microbiota, dysbiosis, and leaky-gut syndrome
T Kobayashi, M Iwaki, A Nakajima, A Nogami… - International Journal of …, 2022 - mdpi.com
Global lifestyle changes have led to an increased incidence of non-alcoholic fatty liver
disease (NAFLD) and non-alcoholic steatohepatitis (NASH), requiring further in-depth …
disease (NAFLD) and non-alcoholic steatohepatitis (NASH), requiring further in-depth …